Allergan
In Carl Icahn's portfolio · Icahn Capital Management
Ticker AGN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Icahn Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2017 | Sell | 0 | |
| Q4 2016 | No change | 425,438 | 0.4% |
| Q3 2016 | Reduce 87% | 425,438 | 0.5% |
| Q2 2016 | Buy | 3,400,000 | 3.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.